Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

AbSci

AbSci
2011 FOUNDED
PRIVATE STATUS
21-30 EMPLOYEES
Series D LATEST DEAL TYPE
$15.4M LATEST DEAL AMOUNT
13 INVESTORS
Description

Operator of a biotechnology company intended to produce proteins for biotherapeutic medical treatments. The company specializes in the production of soluble, disulfide proteins ranging from monoclonal antibodies to insulin in a semi-oxidized cytoplasm through secretion into the periplasmic space, thereby allowing the healthcare industry to mass-produce medical compounds.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 101 East 6th Street
  • Suite 350
  • Vancouver, WA 98660
  • United States

+1 (360) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AbSci’s full profile, request a free trial.

AbSci Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series D) 18-Dec-2019 $15.4M 000.00 Completed Generating Revenue
6. Later Stage VC (Series C) 30-May-2018 0000 000.00 Completed Generating Revenue
5. Later Stage VC (Series B) 07-Aug-2017 00.00 Completed Generating Revenue
4. Early Stage VC (Series A) 11-Apr-2016 00.00 00.00 0000 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2013 Completed Generating Revenue
2. Grant Completed Generating Revenue
1. Angel (individual) Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

AbSci Competitors (28)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioVision Formerly VC-backed Milpitas, CA 000 000000&0
00000 0000000000 Formerly VC-backed San Francisco, CA 000 00000 00000000 00000
000000000 Corporation San Diego, CA 000
00000000 Venture Capital-Backed Düsseldorf, Germany 0000000000
000000 00000000000 Venture Capital-Backed Quebec, Canada 000.00 0000000000 000.00
To view this company’s complete list of competitors, request access »

AbSci Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
JSR Life Sciences Other Minority 000 0000 000000 0
KBI BioPharma Corporation Minority 000 0000 000000 0
AGC (Tokyo) Corporation Minority 000 0000 000000 0
Columbia Ventures PE/Buyout Minority 000 0000 000000 0
Greenbridge Partners Other Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

AbSci Executive Team (5)

Name Title Board
Seat
Contact
Info
Sean McClain Co-Founder, Chief Executive Officer and Board Member
Shelley Klassen Chief Financial Officer
Suzanne Sprunger Ph.D Chief Intellectual Property Officer
Mark Valasek Co-Founder
Philip Barish Ph.D Vice President of Operations

AbSci Board Members (6)

Name Representing Role Since Contact
Info
Bryan Lawlis AbSci Board Member 000 0000
Daniel Gold Ph.D AbSci Board Member 000 0000
Gustavo Mahler Ph.D Self Board Member 000 0000
Loretta Little WRF Capital Board Member 000 0000
Sean McClain AbSci Co-Founder, Chief Executive Officer and Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »